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 ABSTRACT 
Pleural sac is an enclosed sac covering the lung that consist of two membranes, i.e. 
parietal and visceral pleura. It has a cavity filled with small amount fluid that plays important 
role to provide smooth sliding of lung during respiration. Change or disturbance in the pleural 
cavity and or the pleura itself may result in restriction of lung expansion causing ventilation 
compromise. 
Pathology of pleura may result from varying etiology. It may present as inflammatory 
pleural effusion, non-inflammatory pleural effusion, pneumothorax, hematothorax, 
fibrothorax, pleural tumors, and cylothorax.  Diagnostic tool for pleural diseases may be made 
from the simplest chest x-ray, ultrasound, computed tomography, MRI and histopathological 
studies. 
There are several treatment options for managing pleural diseases. It consist non 
operatif treatment, pleural drainage, decortication or pleurectomy, pleurodesis, and/ or 
resection of pleural tumor through procedure VATS, or open thoracotomy. Indications for 
surgery are traumatic or spontaneous pneumothorax, hematothorax, cylothorax, failure of non 
operatif treatment, fibrothorax or schwarte limiting lung expansion, mesothelioma, and 
recurrent pneumothorax or malignant pleural effusion. Decision for surgery need appropriate 
timing and planning regarding different pathology and different etiology. 
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INTRODUCTION  
 Pleural disease is one of the most 
common diseases, every year in the UK 
there are 3000 people  per million 
population affected. Pleural disease comes 
from a broad pathological scope and is a 
systematic approach and requires proper 
examination and management.3 Surgery in 
pleural disease has developed quite slowly, 
with many not following modern advances 
in pleural surgery.2 
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 Techniques that are less invasive 
that can be used and provide good results 
are thoracoscopy and VATS (Video-
Assisted Thoracic Surgery). VATS is very 
widely accepted among surgeons and is 
liked by many patients because the 
technique is less invasive.7 
1. Pleural Surgery in 
Pneumothorax or Pleural Effusion 
 Pleural effusion is a collection of 
fluid in the pleural cavity between the chest 
wall and the lung. This causes chest 
discomfort, coughing, or shortness of 
breath.24 Recurrent pleural effusion often 
occurs. This is caused by a process that is 
benign or malignant in the pleura. 
Management that can be done in the form 
of pleural drainage, thoracocentesis, 
pleurectomy, pleurodesis, or 
pleuroperitoneal shunt.24 
 Pleurodesis is a minor surgical 
procedure that can be a permanent solution 
for reccurent malignant pleural effusion 
(MPE). This technique is done by inserting 
an inflammatory chemical into the pleural 
cavity which causes the formation of a scar 
between the lung and chest wall as an 
inflammatory response. This scar causes 
space in the lung and chest wall to be closed 
so that the fluid no longer collects here. The 
liquid inside can be absorbed more easily 
by the body. this technique has a success 
rate of 30%.23 
2. Pleural Surgery for Infection 
(Empyema) 
 Empyema is an inflammatory 
process in the visceral or parietal pleura. 
Empyema has complex things to discuss 
and have unique clinical symptoms. there is 
a dominant inflammatory process, 
ptatological differences and there are 
various treatment techniques for  
this case.12
 




Figure 1. Cause of Pleural Effusion (Adopted from Perikleous P) 14 
 
Figure 2. Treatments for Recurrent Malignant Pleural Effusion (Adopted From West H. 
)24Pneumonia and subsequent parapneumonic effusion are the most common causes of empyema.  
Other causes are penetrating or blunt chest 
injury, bronchogenic carcinoma, 
mediastinitis, esophageal rupture, 
expansion of below diaphragm, thoracic, 
and cervical spine infection, congenital 
cysts from the airway and infected 
esophagus. The use of broad spectrum 
antibiotics and vaccines for pneumococci 
should be given to patients with 
empyema.21 
 Patients with pleural empyema who 
have a risk of Methicilliin Resistent 
Staphylococcus Aureus and gram negative 
infection, can be given a third generation of 
cephalosporin (ceftriaxone) or 
aminopenicillin with β-lactamase inhibitors 
(ampicillin / sulbactam). Anaerobic 
organisms must be treated empirically, 
where ampicillin / sulbactam can be given 
to these organisms, whereas ceftriaxone 
must be given in conjunction with other 
drugs such as metronidazole. if anaerobic 
bacterial infection occurs in respiratory or 
upper gastrointestinal, clindamycin can be 
used instead of metronidazole. If 
postsurgical infection occurs, the 
antibiotics that can be used are vancomycin, 
flagyl and cefepime, or vancomycin and 
piperacillin / tazobactam (very adequate for 
Pseudomonas aeruginosa). For patients 
with a history or suspect extended spectrum 
β-lactamase-producing organisms can be 
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given vancomycin and meropenem. 
Aminoglycosides are not recommended 
because they are not active in empyema 
fluid. Until now there is still no evidence 
base that proves that direct administration 
of antibiotics to pleural space provides 
better results than systemic antibiotics.21 
 Decortication is the treatment of 
choice for empyema with a lung that 
collapses and can't expand due to a thick 
sheath of inflammation. Decortication is 
usually used for tuberculotic management 
and post-traumatic trapped lung. This 
technique aims to restore lung elasticity and 
free pulmonary parenchyma from the 
pressure of the inflammatory sheath. In 
stage III empyema, there is a decrease in 
pulmonary perfusion of 20-25% on the 
infected side. Where stage III empyema is 
equivalent to empyema which has occurred 
more than 6 weeks. At this stage, Fowler-
Delorme's procedures were recommended, 
especially for postpneumonic empyema or 
accompanying trauma.12 
Decortication can increase FEV1 from 50% to 
69% and vital capacity from 62% to 80%. 
however, the function of the infected lung is 
still disrupted. Ventilation/lung perfusion 
improvement depends on multilevel functional 
lung damage. Patients with posttuberculotic 
with lung collapse and perfusion are minimal, 
decortication can be done, but the results are 
unpredictable. This technique is useful for 
patients with visible clinical symptoms and is 
not indicated for asymptomatic patients.12 
3.Pleural Surgery for Pleural 
Cancers 
 Pleurectomy/decortication (P/D) 
are two sequences of procedures. 
Pleurectomy aims to open the chest and 
open the pleura around the affected tissue. 
While decortication to remove visible 




Figure 3. Stage of Empyema (Adopted From Mionar TF) 12 





Figure 4. Time Scale for Different Stages of Thoracic Empyema and Treatment 
(Adopted From Perikleous P) 14 
Previously, pleurectomy was commonly 
used for the management of pleural 
mesothelioma to reduce fluid around the 
lungs and to reduce pain, but since the 
surgical technique developed, decortication 
can be done. Generally these two 
techniques are combined. This technique 
takes several hours to be completed and the 
success rate depends on the thoracic 
surgeon's skills.6 
To be able to do major surgery in 
mesothelioma patients, the patient's 
condition must be stable and the 
mesothelioma he suffered is still in the 
initial stage. Pleurectomy/decortication can 
improve the survival rate and quality of life 
of patients, especially if combined with 
chemotherapy, radiation therapy, and other 
therapies. VATS (Video-assisted 
Thoracoscopic Surgery) is one of the 
treatment options and open surgery was 
performed if a larger tumor is found. 
1,9,11,17,22 
4. Pleural Surgery for Chylothorax 
Cylothorax is a collection of 
chylous fluid in the thorax cavity. This 
often occurs because of the leakage of 
lymphatic vessels in the thoracic duct. other 
causes are cardiothoracic surgery, 
penetrating or blund injury between the 
neck and upper abdomen, and other 
diseases such as lymphoma. The choice of 
therapy can be non operative and 
operative.4,13,18  
When Do We….. Tahalele PL, Dwintasari M, Motulo Y, Sembiring  





Figure 5. Pleural Surgery for Pleural Cancer (Adopted From Ismail-Khan R)6 
The most preferred management is 
ligation of thoracic duct and it has a success 
rate of 95%. Where this success rate also 
depends on the procedure performed either 
on the azygos vein or descending aorta and 
the structure around the posterior 
mediastinum. Thoracic duct is a thin 
structure, has a occasional peristaltic, and 
tubeshaped. This duct can be dissected or 
stapled or clipped. If there is sufficient 
length, this duct can be excised and 
histopathological examination is 
performed. Ligation of the supra-
diaphragmatic duct has a success rate of 
90% but pleurodesis is not indicated in 
patients with trapped lung and prolonged 
effusion.10 
there are several surgical options for 
thoracic duct ligation based on the location 
of the leakage and its etiology. Consuming 
milk or cream before surgery or injecting 
1% evans blue dye on the thigh can clarify 
thoracic duct during VATS or open 
thoracotomy.16 
5. Pleural Surgery for Hematotoraks 
 Hematothorax can occur due to 
trauma or non trauma. The most common 
causes are trauma, but non-traumatic causes 
such as aortic aneurysm, pulmonary 
embolism, haemostatic abnormalities or 
melignant metastatic disease can also 
occur.5 VATS can identify and control 
bleeding and can clear the pleural cavity 
from the clots. In addition, chest tube was 
also needed. Open thoracotomy must be  





F igure 6. Surgery for Cylothorax (Adopted From Perikleous P) 1 
performed in patients with multiple trauma 
and massive bleeding. 15 The clinical 
symptoms can be pain that is localized to an 
area that is inflamed or referred pain 
according to the nerve pathway Other 
symptoms can be difficulty breathing, 
sneezing, coughing, which exacerbates pain. 
Pain is described as sharp pain and gets 
worse with movement. 8 
 Basically the parietal and visceral 
pleura have a smooth surface, but can be 
rough due to inflammation, so that at the 
physical examination friction rub or rough 
scratching sound can be heard during 
inspiration and expiration.8 
 There are several less invasive 
techniques for diagnosing and evaluating 
pelural disease, namely closed pleural 
biopsy, thoracosynthesis, guided image 
biopsy (CT or ultrasound), video-assisted 
Thoracoscopy surgery (VATS), medical 
thoracoscopy, and open thoracotomy.The 
main purpose of pleurisy therapy is (1) 
reducing pleuritic pain with analgesic drugs 
usually nonsteroidal anti-inflammatory 
drugs (NSAIDs) and (2) managing 
underlying diseases. 8 
 
Figure 7. Lung With Pleurisy and Pneumothorax (Adopted From Kass SM)8 
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Surabaya Pleural Surgery Experiences 
  
Figure 8. Female, 57 years old with Cylothorax. The patient initially had pneumonia and 
was treated in the lung room for 1 month. She also had right pleural effusion and drainage 
was perfomed. It appears cloudy white liquid like milk out of the drain as much as 1.5 liters. 
Pleural fluid analysis was done and the results of triglycerides 3 mmol / l (normal <1.24 
mmol /l) and cholesterol 18 (normal <5.18 mmol /l). 
 
Figure 9. X-Ray Thorax, 6-2-2017 
Table 1. Laboratorium Finding in Cylothorax 
 
Result of Our Patient’s; 
Pleural Fluid Analysis 





Figure 10. Patient condition after chest tube release 
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Figure 12. Man, 19 years old with  Right Fluidopneumothorax + Pleuritis TB + Pulmonary 
TB with negative Acid Fast Bacilli (AFB) + Bronkiektasis pro Decortication, (a) Cilical 
Figure, (b) Thorax X-Ray with multiple air fluid level, thickening of the parietal and visceral 
pleura, and right lung collapse 
   
(a) (b) (c) 




Figure 13. Operating site (a) & (b) before decortication seem fluid trapped inside the right 
thorax cavity, thickening of the parietal and visceral pleura, and right lung collapse, (c) after 
decortication the lung expand ± 80% and look reddish 
  
(a) (b) 
Figure 14. (a) Parietal and Visceral pleural peel (b) Pleural fluid for microbiology 
examination 
 
Figure 15. Chest X-Ray one day after Decortication, lung expand ± 80% 
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CASE 3  
  
(a) (b) 
Figure 16. Woman, 50 years old with left fluidopneumothorax and Pulmonary TB, (a) before 
chest tube insertion seem thickening of parietal pleura, lung totally collapse, and left 
fluidopneumothorax (b) after chest tube insertion seem lung expand ± 30% and thickening 
of parietal and visceral pleura 
   
(a) (b) 
Figure 17. Operating site (a) before operation, lung collapse 30%, (b) after operation lung 
expand 70-80% 






Figure 18. After decortication, (a) parietal and visceral pleura peel, (b) 1 week after 
decortication, chest tube was released and lung expand 80% 
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